Oscillating expression of a key cancer gene may impact treatment approaches for patients NFCR-supported scientist Dr. Daniel Haber and his team at the Massachusetts General Hospital Cancer Center have identified a dynamic gene expression in metastatic breast cancer that may contribute to disease progression and resistance to treatment experienced by many…...
Genetic Sequencing and Diagnosis Sets a Guinness World Record
Can you imagine that a Guinness world record could be related to genetic sequencing and disease diagnosis? A world record for fastest genetic diagnosis was recently set by Dr. Stephen Kingsmore, president and CEO of Rady Children’s Institute for Genomic Medicine. Dr. Kingsmore is able to successfully diagnose critically ill…...
Genetic Testing for Cancer: What You Should Know
Genetic testing, including the tests using the second generation sequencing technology, is becoming an very important tool to improve the quality of medical care to cancer patients and high risk population. But, unless the right testing is selected, the results of the gene sequencing won’t be able to help the…...
Honoring Rakesh K Jain, Ph.D. NFCR funded Scientist
We are so pleased to congratulate National Foundation for Cancer Research funded Scientist Rakesh K. Jain Ph.D. on his tribute event today in Cambridge Massachusetts. A great honor to be feted by his collaborators, peers and fellow scientists and educators at Harvard Medical School and the E.L. Steele Laboratories for…...
National Foundation for Cancer Research and KEW, Inc. announce a collaboration
National Foundation for Cancer Research and KEW, Inc. announce a collaboration to increase awareness of the value of genetic testing. Big Data comes to Cancer Care Choices. #Research4aCure BETHESDA, Maryland (June 8, 2016) – The National Foundation for Cancer Research (NFCR) and Kew, Inc, a private oncology services company based…...
Strategic Media Partner
